Prevalence of Toxoplasma gondii and Cytomegalovirus in Sera of Aborted Women in Samaraa city
Main Article Content
Abstract
The aim of this study was to detect the relationship between Toxoplasmosis, Cytomegalovirus infections and occurrence of abortion. The records of 173 aborted women between age of less than twenty years and fifty years old attending to the hospital of Samaraa general hospital from October 2015 to April 2016 were reviewed. Investigation by using VIDAS technique represented that T. Gondii antibodies showed in 54(31.2 %) of aborted women ,while 23(13.3 %) represented infected with Cytomegalovirus and 7(4.1%) were infected with both Toxoplasmosis and Cytomegalovirus. Also the study showed that 77 (44.5%) of aborted women were in aged groups between 21-30 years old ,and the anti-toxoplasmosis IgM &IgG found in 66(38.2%) and anti-cytomegalovirus IgM &IgG found only in 30(17.34%) in aborted women.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Messaritakis I., Detsika M., Koliou M., Sifakis S., and Antoniou M.(2008) Prevalent Geno-types of Toxoplasma gondii in Pregnant Women and Patients from Crete and Cyprus. Ameri. Soci. Tropi. Medi. and Hygi.,79 (2). 205-209.
2- Gohel T., Pawar S., Turbadkar D., Baveja S. (2014). Seroprevalence and clinical correlates of Toxoplasma gondii Infection among pregnant women in Tertiary Care Hospital. Int. J. Sci. Stud. ,2(8):29-33.
3- Montoya J. and Liesenfold O.(2004). Toxoplasmosis. Lancet, 363:1955-1976.
4- Jeffrey L., Deanna K., Marianna W. , Geraldine M. , Thomas N. and James B. Toxoplasma gondii infection in the United States: seroprevalence and risk Factors.(2001). Am. J. Epidemiol. , 154 (4): 357-365.
5- Paschale De M., Carlo A., Maria T., Alessia P., Pierangelo C. (2009). Incidence and risk of cytomegalovirus infection during pregnancy in an urban area of northern Italy, Infect. Dis. Obstet. Gynecol, (10):11 5-20.
6- Rubina F.. Bashir T., Tehmeena W., Dalip K., Rubina S., Asifa N. (2004). Seroprevalence of Cytomegalovirus(CMV) in Kashmir valley. J. K. Practitioner., 11: 261-262.
7- Mocarski E. S. Cytomegaloviruses and their replication, 3rd,Lippincott-Raven, Philadelphia; 2447-2492.
8- Hedman , M. Lappalainen M., Söderlund M., and Hedman L. (1993). Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol., 4:123-129.
9- Petersen E., Borobio, E. , O. Liesenfeld, Meroni, A. Naessens E. Spranzi and P. Thulliez. (2005). European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol., 43:1570-1574.
10- Candolfi E., Pastor R., Huber R., Filisetti D., and Villard O. (2007). IgG avidity assay firms up the diagnosis of acute Toxoplasmosis on the first serum
sample in immunocompetent pregnant women. Diagn. Microbiol. Infect. Dis., 58:83-88.
11- Horváth K. , Szénási Z., Danka J., and Kucsera I. (2005). Value of the IgG avidity in the diagnosis of recent toxoplasmosis: a comparative study of four commercially available anti-Toxoplasma gondii IgG avidity assays. Acta. Parasitol., 50:255-260.
12- Thapliyal N. , Jain G., and Pandey G. (2005).Torch test need for use as a screening test. Indian J. Practicing Doctor ,1 ( 4) .
13- Mohammed J. and Hadeel A.(2011). Performance of serological diagnosis of TORCH agents in aborted versus non aborted women of waset province in Iraq. Tikrit. Med. J., 17(2): 141-147
14- Hussein A., Mohammed, A., and Rebah N.(2014) .seroprevalence of human cytomegalovirus (HCMV) in aborted women in Baghdad province. Int. J. Curr. Microbiol. App. Sci , 3(2): 97-102 .
15- Trost JE. (1986). Abortions in relation to age, coital frequency, and fecundity. Arch. Sex. Behav. , 15(6):505-509.
16- Gilda S., Akinrinola B., Susheela S., and Michelle E.(2012). Legal abortion levels and trends by woman’s age at termination.International perspectives on sexual and reproductive health, 38(3):143–153.
17- Elise R. and Patrick T. (2002). Paternal age and maternal age are risk factors for miscarriage; results of a multicentre european study. Oxfo. J., 17( 6):1649-1656.
18- Anmar A. (2010). Serological study for TORCH Infections In women with high delivery risk factors In mosul. Tikrit. J. of Pur. Sci., 15 (1):193-198.
19- Sue G., Boyer M., Kenneth M. and Boyer M. (2004) TORCH infections in the newborn infant. , 4 (5).
20- Sood S., Pillai P. and Raghunath C. (1994). Infection as a cause of spontaneous abortion with special reference to Toxoplasma gondii, rubella virus, CMV and Treponema pallidum. Ind. J. Med. Microbiol, 12: 204-207.
21- Montoya J. and Rosso F. (2005). Diagnosis and management of toxoplasmosis. Clin. Perinatol., 32:705-726.
22- Adler S. (2011). Screening for cytomegalovirus during pregnancy. Infect. Dis. Obstet. Gynecol., 10:1-9.
23- Staras S.A. Dollard S.C, Radford K.W, Flanders W.D, Pass R.F and Cannon M.J. (2006). Seroprevalence of cytomegalovirus infection in the United States1988-1994. Clin. Infect. Dis., 43:1143-1151.
24- Jalil I. and Abbas U. (2008). Toxoplasmosis and cytomegalovirus infection among aborted women in Al-Anbar governorate.,6(1): 70-82.
25- Maysara S., Dhammra W., Khalida A.(2012). The seroprevalence of IgM among iraqi aborted
women infected with human cytomegalovirus. Iraq. Pos. Medi. J., 11 (1):124-129.
26- Nada G., Fawzia A. (2015). Seroprevalence of Toxoplasma gondii and cytomegalovirus in aborted women in Baghdad-Iraq. Iraq. J. Sci., 56 (1) : 649-655.
27- Salih A. and Kazhal J. (2013). Human cytomegalovirus IgG and IgM seropositivity among pregnant women in Sulaimani city and their relations to the abortion rates. Curr. Res. J. Biol. Sci., 5(4): 161-167.
28- Fowler K., Stagno S. and Pass R.F. (1993).
Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J. Infect. Dis., 168:552-56.
29- Fowler, K., Stagno S., and Pass R. (2003).Maternal immunity and prevention of congenital cytomegalovirus infection. J. Ameri. Med. Asso . ,289(8):1008-1011.
30- Pedron B., Guerin V., Jacquemard F., Munier A., Daffos F., Thulliez P., Aujard Y., Luton D. Sterkers G.(2007). Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J. Infect. Dis.,196:1033-1043.
31- Tagno S., Pass G., Cloud W., et al.(1986). Primary cytomegalovirus infection in pregnancy incidence, transmission to fetus, and clinical outcome .J. Ameri. Med. Asso. , 258:1904-1908.
32- Fisher S., Genbacev O., Maidji E., and Pereira L. (2000). Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J. Virol., 74:6808- 6820.
33- Salman L. and Juma S. (2009) Correlation between apoptosis and Toxoplasma in abortion induction: relevance of TUNEL assay. Euro. J. Scie. Rese,37 (3): 406-425.
34- Montoya J. and Remington J. Toxoplasma gondi . In Man-dell G., Douglas R., Bennett J., Dolin R. (Eds.). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, (2000) Churchill Livingstone. 2858-2888.
35- Wilson M. and McAuley J. Toxoplasma. In: Murray, P.R. Ed. Manual of clinical microbiology. 7th ed. Washington, (1999),D.C. American Society for Microbiology. 1374-1382.
36- Turbadkar D., Mathur M., Pele M. (2003) Seroprevelance of TORCH infection in bad obstetric history. Indi. J. Med. Microbiol. , 21(2):108-110.
37- Abu- Zeid Y. (2002). Serological evidence for remarkably variable rates of Toxoplasma gondii in children of major residential areas in United Arab Emirates. Acta. Tropica., 83(1):63-69 .
38- Rana F., Baqur A., Sabah N. (2016). Relationship between Toxoplasma gondii and abortion in aborted women in Najaf province. J. Kerb. Univ., 14 (1):177-185 .
39- Donner C., Liesnard C. and Content J. (1993). Prenatal diagnosis of 52 pregnancies at risk for
congenital cytomegalovirus infection. Obstet. Gynecol., 82: 481-486.